How TMS therapy works
TMS therapy is administered by placing a treatment Vitobrain Review coil lightly against the scalp of a patient while they sit in a reclining chair. The coil then emits magnetic fields directly to the portion of the brain involved with mood regulation. Small electrical currents are produced by the magnetic fields. The currents proceed to alter cell activity in the brain, which is thought to be effective in reducing depression symptoms.Treatment lasts about 40 minutes a session, with patients fully awake during the process. Patients typically have five weekly treatments over a six week period. The most common side effect associated with treatment during clinical trials was scalp pain or discomfort - generally mild to moderate.
Studies have found most patients respond best to treatments of 40 consecutive magnetic pulses to the brain over a four second period twice a minute. However, duration, frequency and the number of pulses received per session depend upon the doctor's assessment of how the patient responds to the treatment.Lower depression relapse rates Two recently-released studies suggest patients with major depression were less likely to relapse following TMS treatment compared to medication or electroconvulsive therapy (ECT).
The studies found only 10 to 12 percent of patients whose depression initially went into remission following TMS treatment experienced relapse. The TMS results sharply contrast to the 40 percent relapse rate experienced by patients achieving remission in a study on anti-depression medication, a statistic similar to relapse rates experienced by ECT patients.The two independently conducted TMS studies were presented this spring during the American Psychiatric Association meeting. Both studies were open to patients who failed previous antidepressant therapies.
Studies have found most patients respond best to treatments of 40 consecutive magnetic pulses to the brain over a four second period twice a minute. However, duration, frequency and the number of pulses received per session depend upon the doctor's assessment of how the patient responds to the treatment.Lower depression relapse rates Two recently-released studies suggest patients with major depression were less likely to relapse following TMS treatment compared to medication or electroconvulsive therapy (ECT).
The studies found only 10 to 12 percent of patients whose depression initially went into remission following TMS treatment experienced relapse. The TMS results sharply contrast to the 40 percent relapse rate experienced by patients achieving remission in a study on anti-depression medication, a statistic similar to relapse rates experienced by ECT patients.The two independently conducted TMS studies were presented this spring during the American Psychiatric Association meeting. Both studies were open to patients who failed previous antidepressant therapies.
Comments
Post a Comment